As of 2026-09-15, the Relative Valuation of C4 Therapeutics Inc (CCCC) is (24.72) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.43 USD, the upside of C4 Therapeutics Inc based on Relative Valuation is -820.7%.
The range of the Relative Valuation is (21.74) - (27.42) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 23.6x - 29.9x | 26.8x |
| Forward P/E multiples | 23.7x - 30.6x | 27.2x |
| Fair Price | (21.74) - (27.42) | (24.72) |
| Upside | -733.8% - -899.6% | -820.7% |
| Date | P/E |
| 2026-09-11 | -3.83 |
| 2026-09-10 | -3.71 |
| 2026-09-09 | -3.75 |
| 2026-09-08 | -3.87 |
| 2026-09-04 | -4.10 |
| 2026-09-03 | -4.08 |
| 2026-09-02 | -4.13 |
| 2026-09-01 | -4.22 |
| 2026-08-31 | -4.04 |
| 2026-08-28 | -4.20 |
| 2026-08-27 | -4.47 |
| 2026-08-26 | -4.62 |
| 2026-08-25 | -4.58 |
| 2026-08-24 | -4.47 |
| 2026-08-21 | -4.36 |
| 2026-08-20 | -4.39 |
| 2026-08-19 | -4.59 |
| 2026-08-18 | -4.56 |
| 2026-08-17 | -4.65 |
| 2026-08-14 | -4.62 |
| 2026-08-13 | -4.45 |
| 2026-08-12 | -4.25 |
| 2026-08-11 | -4.22 |
| 2026-08-10 | -3.95 |
| 2026-08-07 | -4.07 |
| 2026-08-06 | -3.97 |
| 2026-08-05 | -3.95 |
| 2026-08-04 | -3.94 |
| 2026-08-03 | -3.82 |
| 2026-07-31 | -3.79 |
| 2026-07-30 | -3.99 |
| 2026-07-29 | -3.84 |
| 2026-07-28 | -3.87 |
| 2026-07-27 | -3.91 |
| 2026-07-24 | -3.71 |
| 2026-07-23 | -3.98 |
| 2026-07-22 | -4.08 |
| 2026-07-21 | -4.18 |
| 2026-07-20 | -3.90 |
| 2026-07-17 | -4.02 |
| 2026-07-16 | -3.90 |
| 2026-07-15 | -4.14 |
| 2026-07-14 | -4.15 |
| 2026-07-13 | -4.27 |
| 2026-07-10 | -4.43 |
| 2026-07-09 | -4.68 |
| 2026-07-08 | -4.57 |
| 2026-07-07 | -4.74 |
| 2026-07-06 | -4.51 |
| 2026-07-02 | -4.69 |